These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 15576057)

  • 1. Cytokines and psychopathology: lessons from interferon-alpha.
    Capuron L; Miller AH
    Biol Psychiatry; 2004 Dec; 56(11):819-24. PubMed ID: 15576057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuro-immune interactions in psychopathology with the example of interferon-alpha-induced depression].
    Capuron L; Dantzer R; Miller AH
    J Soc Biol; 2003; 197(2):151-6. PubMed ID: 12910630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines and brain function: relevance to interferon-alpha-induced mood and cognitive changes.
    Licinio J; Kling MA; Hauser P
    Semin Oncol; 1998 Feb; 25(1 Suppl 1):30-8. PubMed ID: 9482538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mood and cognitive side effects of interferon-alpha therapy.
    Valentine AD; Meyers CA; Kling MA; Richelson E; Hauser P
    Semin Oncol; 1998 Feb; 25(1 Suppl 1):39-47. PubMed ID: 9482539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuropsychiatric symptoms related to interferon alpha].
    Małyszczak K; Inglot M; Pawłowski T; Czarnecki M; Rymer W; Kiejna A
    Psychiatr Pol; 2006; 40(4):787-97. PubMed ID: 17068950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric adverse effects of interferon-alpha: recognition and management.
    Raison CL; Demetrashvili M; Capuron L; Miller AH
    CNS Drugs; 2005; 19(2):105-23. PubMed ID: 15697325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential multiple-assignment randomized trial design of neurobehavioral treatment for patients with metastatic malignant melanoma undergoing high-dose interferon-alpha therapy.
    Auyeung SF; Long Q; Royster EB; Murthy S; McNutt MD; Lawson D; Miller A; Manatunga A; Musselman DL
    Clin Trials; 2009 Oct; 6(5):480-90. PubMed ID: 19786415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-alpha influences tryptophan metabolism without inducing psychiatric side effects.
    Bannink M; Fekkes D; Van Gool AR; Kruit WH; Sleijfer S; van der Holt B; Eggermont AM; Stoter G; Hengeveld MW
    Neuropsychobiology; 2007; 55(3-4):225-31. PubMed ID: 17873497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol.
    Wichers MC; Kenis G; Koek GH; Robaeys G; Nicolson NA; Maes M
    J Psychosom Res; 2007 Feb; 62(2):207-14. PubMed ID: 17270579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy.
    Capuron L; Pagnoni G; Demetrashvili MF; Lawson DH; Fornwalt FB; Woolwine B; Berns GS; Nemeroff CB; Miller AH
    Neuropsychopharmacology; 2007 Nov; 32(11):2384-92. PubMed ID: 17327884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C.
    Laguno M; Blanch J; Murillas J; Blanco JL; León A; Lonca M; Larrousse M; Biglia A; Martinez E; García F; Miró JM; de Pablo J; Gatell JM; Mallolas J
    Antivir Ther; 2004 Dec; 9(6):905-9. PubMed ID: 15651749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism.
    Russo S; Kema IP; Haagsma EB; Boon JC; Willemse PH; den Boer JA; de Vries EG; Korf J
    Psychosom Med; 2005; 67(5):773-7. PubMed ID: 16204437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis C.
    Amodio P; De Toni EN; Cavalletto L; Mapelli D; Bernardinello E; Del Piccolo F; Bergamelli C; Costanzo R; Bergamaschi F; Poma SZ; Chemello L; Gatta A; Perini G
    J Affect Disord; 2005 Jan; 84(1):93-8. PubMed ID: 15620390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise.
    Felger JC; Miller AH
    Front Neuroendocrinol; 2012 Aug; 33(3):315-27. PubMed ID: 23000204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychiatric complications of interferons: classification, neurochemical bases, and management.
    Malek-Ahmadi P; Hilsabeck RC
    Ann Clin Psychiatry; 2007; 19(2):113-23. PubMed ID: 17612851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychopathology of schizophrenia and brain imaging].
    Gross G; Huber G
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome.
    Meyers CA; Albitar M; Estey E
    Cancer; 2005 Aug; 104(4):788-93. PubMed ID: 15973668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha reduces the density of monoaminergic axons in the rat brain.
    Ishikawa J; Ishikawa A; Nakamura S
    Neuroreport; 2007 Jan; 18(2):137-40. PubMed ID: 17301678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon, tryptophan and depression.
    Fekkes D; Van Gool AR
    Acta Neuropsychiatr; 2003 Feb; 15(1):8-14. PubMed ID: 26984700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major depressive disorder with psychotic features induced by interferon-alpha treatment for hepatitis C in a polydrug abuser.
    Kalyoncu OA; Tan D; Mirsal H; Pektas O; Beyazyurek M
    J Psychopharmacol; 2005 Jan; 19(1):102-5. PubMed ID: 15671136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.